Stevens-Johnson Syndrome in a patient diagnosed with HIV and syphilis

Authors

  • Mercedes Sabatini Dr. Cosme Argerich General Acute Care Hospital, City of Buenos Aires, Argentina
  • Yanina Berberian Dr. Cosme Argerich General Acute Care Hospital, City of Buenos Aires, Argentina
  • María Inés Hernández Dr. Cosme Argerich General Acute Care Hospital, City of Buenos Aires, Argentina
  • Sabrina Meik Dr. Cosme Argerich General Acute Care Hospital, City of Buenos Aires, Argentina
  • Vicenta Ana M. Neglia Dr. Cosme Argerich General Acute Care Hospital, City of Buenos Aires, Argentina

DOI:

https://doi.org/10.47196/3qtnze21

Keywords:

Stevens-Johnson syndrome, HIV, syphilis, drug induced skin reactions

Abstract

Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare adverse drug reactions that are part of the same spectrum of disease. They are differentiated by the extent of skin detachment, and SJS is considered when it is less than 10%. The prevalence of SJS in HIV-positive patients is up to 1000 times higher than in the rest of the population, probably secondary to an alteration in the T-cell-mediated immune response. We present the case of a female patient with SJS who during hospitalization was diagnosed with HIV and syphilis, both unknown until now.

Author Biographies

  • Mercedes Sabatini, Dr. Cosme Argerich General Acute Care Hospital, City of Buenos Aires, Argentina

    Medical Resident, Dermatology Specialization Program, University of Buenos Aires (UBA)

  • Yanina Berberian, Dr. Cosme Argerich General Acute Care Hospital, City of Buenos Aires, Argentina

    Staff Physician

  • María Inés Hernández, Dr. Cosme Argerich General Acute Care Hospital, City of Buenos Aires, Argentina

    Staff Physician

  • Sabrina Meik, Dr. Cosme Argerich General Acute Care Hospital, City of Buenos Aires, Argentina

    Staff Physician

  • Vicenta Ana M. Neglia, Dr. Cosme Argerich General Acute Care Hospital, City of Buenos Aires, Argentina

    Head of the Dermatology Unit

References

I. Racca-Velásquez F, Saurith-Daza ZJ, Benítez-Arce SC. Síndrome de Stevens-Johnson: informe de un caso. Salud i Ciencia 2024;26:203-209.

II. Hotzenecker W, Prins C, French LE. Eritema multiforme, síndrome de Stevens-Johnson y necrólisis epidérmica tóxica. En: Bolognia JL, Schaffer JV, Cerroni L, eds. Dermatología. 4º ed. Barcelona: Elsevier; 2018:337-345.

III. Lagrew M, Perryman K, Walker A, Hahn P. Stevens-Johnson Syndrome (SJS) as the initial presentation in a patient with a new diagnosis of HIV. Cureus. 2023;15:e50277.

IV. Tassier C, Anodal M, Villani ME, Sánchez G, et al. Farmacodermias: un estudio prospectivo. Dermatol Argent. 2014;20:176-187.

V. Jossy T, Maury T, Mutizwa M. HIV-associated toxic epidermal necrolysis at San Francisco General Hospital: a 13-year retrospective review. J Int Assoc Provid AIDS Care. 2017;16:37-41.

VI. Yang C, Mosam A, Mankahla A, Dlova N, et al. HIV infection predisposes skin to toxic epidermal necrolysis via depletion of skin-directed CD4+ T cells. J Am Acad Dermatol. 2014;70:1096-1102.

VII. Gómez A, Alvez I, Cabrera J. Farmacodermias severas: experiencia del Centro Nacional de Quemados (CENAQUE) de Montevideo, Uruguay. Rev Argent Quemaduras. 2020;30:1-9.

VIII. Hasegawa A, Abe R. Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis. F1000Res. 2020;9:612.

IX. Shah H, Parisi R, Mukherjee E, et al. Update on Stevens-Johnson syndrome and toxic epidermal necrolysis: diagnosis and management. Am J Clin Dermatol. 2024;25:891-908.

Downloads

Published

2026-07-16

Issue

Section

Clinical Cases